focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition

7 Jan 2020 07:00

RNS Number : 9147Y
Barkby Group PLC (The)
07 January 2020
 

7 January 2020

The Barkby Group Plc

("the Company")

Completion of Acquisition 

Admission of the New Ordinary Shares to trading on AIM and Directors Shareholding

The Barkby Group PLC, the consumer-focused hospitality group, confirms that the Company's Existing Ordinary Shares trading on NEX Exchange has today been cancelled. Application has been made to the London Stock Exchange for the Enlarged Share Capital to be admitted to trading on AIM ("Admission") and it is expected that Admission will occur and dealings will commence by 8.00 a.m. today.

On Admission, the Company will complete the acquisitions of Tarncourt Ambit Properties Limited, Tarncourt Ambit Limited and Workshop Trading Holdings Limited (together the "Dickson Controlled Entities") and the Placing and Subscription ("Completion"). 

This follows the announcements on 19 December 2019 in relation to the Reverse Takeover, Placing and Subscription and on 6 January 2020 in relation to the passing of the Resolutions at the General Meeting.

Following Admission and Completion, the total number of Shares in issue will be 135,235,066. There are no Shares held in treasury. Accordingly, the total number of voting rights in the Company on Admission will be 135,235,066. This figure may be used by Shareholders as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Giles Clarke (Non-Executive Chairman) and Rupert Fraser (Chief Executive Officer) subscribed at the Issue Price for 250,000 and 666,667 New Ordinary Shares in the Placing and Subscription respectively. The tables below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail on the transaction.

Charles Dickson, Executive Chairman of The Barkby Group Plc, commented:

"This is a transformational acquisition for all of us and I am very excited to be leading the business as Executive Chairman. The Group now consists of a diverse portfolio of high growth, high quality businesses and several very exciting early stage businesses with the potential to significantly disrupt the markets within which they operate.

"Our enhanced scale and capital will provide a strong platform for growth and deliver value for our shareholders. I would like to thank all our stakeholders for their continued support as the business moves into a new chapter."

Defined terms used in this announcement will have the meaning (unless the context otherwise requires) as set out in the Admission Document which is available on the Company's website www.barkbygroup.com. This announcement should be read in conjunction with the Admission Document published by the Company on 19 December 2019.

Enquiries: 

finnCap Ltd (Corporate Adviser and Broker)

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)

 

+44 (0) 20 7220 0500

Camarco (Financial PR)

Jennifer Renwick/Jane Glover

+44 (0) 20 3757 4994

 

Notes to editors

The Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses within Barkby include; Commercial Property Development, Barkby Hospitality (comprising Barkby Pubs and Workshop Coffee) and Centurian Automotive. In addition to these businesses, Barkby has the right to participate in the upcoming fundraisings for two disruptive high growth private companies: Transcend Packaging, a sustainable and innovative paper packaging manufacturer aiming to eliminate single use plastic, and VivoPlex, a digital health company aiming to transform fertility treatment with precision medicine. Barkby's strategy is to accelerate and maximise opportunities within its existing businesses as well as continue to source and invest in cash generative, growth businesses with the ability to disrupt.

Directors Shareholding

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Rupert Fraser

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

 

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

The Barkby Group Plc

b)

LEI:

213800X57YXZVILB9E84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 30 pence each

 

GB00B13GSS58

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

30 pence

666,667

 

 

d)

Aggregated information:

Aggregated volume:

Price:

As above

e)

Date of the transaction:

6 January 2020

f)

Place of the transaction:

NEX Exchange

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Giles Clarke

2.

Reason for the notification

a)

Position/status:

Non-Executive Chairman

 

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

The Barkby Group Plc

b)

LEI:

213800X57YXZVILB9E84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 30 pence each

 

GB00B13GSS58

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

30 pence

250,000

 

 

d)

Aggregated information:

Aggregated volume:

Price:

As above

e)

Date of the transaction:

6 January 2020

f)

Place of the transaction:

NEX Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NEXUNUARRAUARUR
12
Date   Source Headline
30th Jan 20246:03 pmRNSChange of Name to Roadside Real Estate plc
2nd Jan 20247:00 amRNSResult of General Meeting
19th Dec 202311:15 amRNSUpdate on debt refinancing and CSS
15th Dec 20237:00 amRNSFirst joint venture acquisition
13th Dec 20235:39 pmRNSPosting of Circular and Notice of General Meeting
4th Dec 20237:00 amRNSIntention to refinance debt facilities
7th Nov 20237:00 amRNSPractical completion of second Roadside asset
31st Oct 20237:00 amRNSFormation of Roadside Real Estate Joint Venture
29th Sep 20237:00 amRNSTrading update
19th Sep 20237:00 amRNSCSS Announces Licensing Deal with Mammoth
11th Sep 20237:00 amRNSResponse to media speculation re CSS
1st Aug 20237:00 amRNSDisposal of Workshop Coffee
14th Jun 20237:42 amRNSCSS announces new licensing agreement
9th Jun 20237:00 amRNSPub portfolio update
6th Jun 20237:00 amRNSMajor licensing deal for Cambridge Sleep Sciences
31st May 20237:00 amRNSPractical completion of first Roadside asset
15th May 20237:00 amRNSBoard Update, Equity Issue & Total Voting Rights
31st Mar 20237:00 amRNSInterim results
22nd Feb 20235:26 pmRNSResult of AGM
16th Jan 20237:00 amRNSNotice of AGM & Debt Facility Drawing
30th Dec 20227:01 amRNSFinal results for the year ended 2 July 2022
30th Dec 20227:00 amRNSRevised debt facility
28th Nov 20227:00 amRNSTrading and Strategy Update
25th Nov 20227:00 amRNSAcquisition of the Eliot Arms
7th Sep 20225:48 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSTrading and Strategy Update
21st Jun 20223:19 pmRNSDirector/PDMR Shareholding
11th May 20225:21 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSExchange of Contracts at Saffron Walden, Essex
1st Apr 20227:00 amRNSAcquisition of The Coach and Horses
30th Mar 20227:20 amRNSInterim Results
4th Mar 20226:09 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSAppointment of Group Property Director
2nd Mar 20227:00 amRNSVerso Biosense completes clinical study
1st Mar 20227:00 amRNSBoard Update
8th Feb 20225:35 pmRNSResult of AGM
3rd Feb 20223:33 pmRNSIssue of Equity and Total Voting Rights
25th Jan 20227:00 amRNSCambridge Sleep Sciences Announces New Partners
18th Jan 20227:00 amRNSVerso Biosense study nears completion
13th Jan 20227:00 amRNSPosting of Annual Report & Notice of AGM
24th Dec 20217:00 amRNSFinal Results for the Year Ended 1 July 2021
20th Dec 20212:06 pmRNSSecond Price Monitoring Extn
20th Dec 20212:00 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSExchange of Contracts in Swindon, Wiltshire
27th Oct 20214:41 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Oct 20212:05 pmRNSSecond Price Monitoring Extn
27th Oct 20212:00 pmRNSPrice Monitoring Extension
27th Oct 202111:05 amRNSSecond Price Monitoring Extn
27th Oct 202111:00 amRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.